Professor
Vita-Salute San Raffaele University
Angelo Lombardo (Ph.D.) is Professor of tissue biology and regenerative medicine at the Vita-Salute San Raffaele University (UniSR; Milan, IT) and Group Leader at the San Raffaele-Telethon Institute for Gene Therapy (SR-Tiget; Milan, IT). His research activities revolve around the development and application of innovative gene and cell therapy strategies, including targeted epigenetic editing. The lab is exploiting this strategy to tackle diseases for which gene silencing is a valid therapeutic option and to develop novel cell engineering approaches for cancer immunotherapy. Angelo is also co-founder of Chroma Medicine Inc. (Boston, USA), a start-up that aims to develop new gene therapy modalities based on targeted epigenetic editing.